Please upgrade your browser.
The aim of this research was to explore activation/deactivation of signaling pathways during cancerogenesis.
Objective: To evaluate the clinical efficacy of sorafenib as preoperative neoadjuvant therapy in patients with high risk renal cell carcinoma (RCC).
“This is a first of its kind meeting in Canada where an all-inclusive group will decide if we are on target, or if we need to refocus our efforts,” says Dr. Michael Jewett.
Levantinib is an oral molecular-targeted agent that selectively inhibits the activities of several different molecules involved in angiogenesis and tumor proliferation...
A new way to identify the most malignant tumors in children has been identified by researchers. The method involves studying genetic ‘micro-variation’, rather than the presence of individual mutations.
Use these URLs to filter the list of clinical trials available on the US government's ClinicalTrials.gov website. Generally, on the trials that are currently recruiting patients will be listed.
However, death rates due to renal cell carcinoma (kidney cancer) have not decreased, indicating that surgery may be of little or no benefit to some patients.
North Carolina Patient & Survivor Meeting, December, 2014.
Clinician Survey Supporting Value Proposition of the Rosetta Kidney Cancer Test™ Published in the Journal of Kidney Cancer.
PLA allows specific protein complexes to be visualized and measured in cancer specimens. This may aid in patient treatment decisions in the future.
|Powered by NeonCRM|